Fontan Udenafil Exercise Longitudinal Assessment Trial - 2

Clinical trial NCT05918211 · RECRUITING

Trial details

NCT number: NCT05918211
Sponsor: Mezzion Pharma Co. Ltd
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Single Ventricle Heart Disease

Start date: 2023-10-30
Primary completion: 2025-10-28
Enrollment: 436

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.